Moreover, LDL degradation was inhibited by 50% with the addition of a neutralizing antibody against IL-6 in the cells from an AML patient with elevated LDL degradation suggesting that IL-6 could be involved in increased LDL uptake process. The gene discussed is IL6; the disease is acute myeloid leukemia.